Pieces of evidence from the studies of stem cell therapy have been shown to achieve therapeutic effects through upregulation of the BDNF/TrkB signalling pathway and enhancement of its downstream cascades, which lead to neuroprotective mechanisms and improved cognitive functions that contribute to mitigation of AD. The gene discussed is NTRK2; the disease is Alzheimer disease.